Publications in collaboration with researchers from University of Zurich (2)

2025

  1. Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

    Blood, Vol. 145, Núm. 2, pp. 202-219

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal